Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port

Table 1

Clinical data on 31 consecutive patients given chemotherapy through a permanent intraperitoneal port placed prior to the closure of the abdomen.

Gender
Male	16
Female	15
Age
Median	49
Range	32–74
Diagnosis
Peritoneal mesothelioma	19
Appendiceal adenocarcinoma	5
Papillary serous cancer	3
Pancreas cancer	3
Rectal cancer	1
Cytoreduction
Complete or near complete (CC-0/CC-1)	23
Incomplete cytoreduction	8
% of patients completing 5 or more cycles of with adverse events requiring removal of intraperitoneal port
Complete or near complete cytoreduction	9% (2/23)
Incomplete cytoreduction	75% (6/8)